Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 85251-85300 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT06331988
Microbiome, Immune-system and Tumor Interaction in Colorectal Cancer
N/A
Recruiting
320 participants
Started: Jul 21, 2022 · Completed: Jul 31, 2029
1 condition
1 sponsor
1 location
NCT05754645
The Microbiome in (Non-) Obese Pregnancy and Pregnancy Outcomes
N/A
Recruiting
110 participants
Started: Jul 21, 2022 · Completed: Aug 21, 2026
3 conditions
1 sponsor
1 location
NCT05313945
Evaluation Patient Satisfaction After Passive Bladder Catheter Removal Compared to Active Removal
NA
Recruiting
160 participants
Started: Jul 21, 2022 · Completed: Mar 21, 2026
1 condition
1 sponsor
2 locations
NCT05458297
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)
PHASE2
Recruiting
223 participants
Started: Jul 21, 2022 · Completed: May 17, 2029
4 conditions
1 sponsor
109 locations
NCT05208307
Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma
PHASE2
Recruiting
34 participants
Started: Jul 21, 2022 · Completed: Oct 21, 2027
1 condition
3 sponsors
1 location
NCT05590247
Role of Intermittent Fasting in Psoriasis and Psoriatic Arthritis
NA
Active, not recruiting
60 participants
Started: Jul 21, 2022 · Completed: Sep 1, 2026
2 conditions
2 sponsors
1 location
NCT05291156
CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy
PHASE2
Recruiting
173 participants
Started: Jul 21, 2022 · Completed: Jul 1, 2025
1 condition
1 sponsor
24 locations
NCT05332925
Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC
N/A
Recruiting
25 participants
Started: Jul 21, 2022 · Completed: Feb 28, 2027
3 conditions
2 sponsors
2 locations
NCT04165486
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy (HORIZON)
PHASE1
Recruiting
40 participants
Started: Jul 21, 2022 · Completed: Sep 30, 2027
1 condition
1 sponsor
14 locations
NCT06179680
White Matter Hyperintensities in Amnestic Mild Cognitive Impairment or Alzheimer's Disease
N/A
Recruiting
142 participants
Started: Jul 21, 2022 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05396170
Effect of Phlebotomy on Heartrate in Polycythemia Patients
N/A
Recruiting
10 participants
Started: Jul 21, 2022 · Completed: Jan 1, 2025
1 condition
1 sponsor
1 location
NCT05376553
Study of Cemiplimab - TP Induction Chemotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck
PHASE1
Enrolling by invitation
24 participants
Started: Jul 20, 2022 · Completed: Oct 31, 2025
1 condition
2 sponsors
1 location
NCT05638724
Munich Long COVID Registry for Children, Adolescents, and Adults
N/A
Recruiting
1,000 participants
Started: Jul 20, 2022 · Completed: Jul 20, 2027
1 condition
11 sponsors
1 location
NCT06190821
Hydrodissection of the Hepatoduodenal Ligament
N/A
Recruiting
13 participants
Started: Jul 20, 2022 · Completed: Feb 20, 2025
1 condition
1 sponsor
1 location
NCT05269680
STAR-LIFE: a Post-market Registry on MINIject
N/A
Recruiting
750 participants
Started: Jul 20, 2022 · Completed: Jul 1, 2026
1 condition
1 sponsor
1 location
NCT05301413
Social Determinants and a Diabetes Prevention Program Tailored for African Americans
PHASE2
Recruiting
360 participants
Started: Jul 20, 2022 · Completed: Feb 28, 2026
2 conditions
5 sponsors
2 locations
NCT05198557
A Study of MT-0551 in Patients With Systemic Sclerosis
PHASE3
Active, not recruiting
80 participants
Started: Jul 20, 2022 · Completed: Aug 31, 2026
1 condition
1 sponsor
4 locations
NCT05361174
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
PHASE1/PHASE2
Recruiting
53 participants
Started: Jul 20, 2022 · Completed: Jun 30, 2027
4 conditions
1 sponsor
10 locations
NCT05675891
Oral Feeding Ability of Preterm Infants With Breastfeeding Support System
NA
Recruiting
60 participants
Started: Jul 20, 2022 · Completed: Dec 31, 2023
2 conditions
1 sponsor
1 location
NCT05379101
Intracardiac Flow Assessment in Cardiac Amyloidosis
N/A
Recruiting
100 participants
Started: Jul 20, 2022 · Completed: Jun 30, 2026
2 conditions
1 sponsor
1 location
NCT05451784
Treatment of Advanced or Metastatic Triple-negative Breast Cancer With Adoptive Therapy of PD1+ TILS
PHASE1/PHASE2
Recruiting
20 participants
Started: Jul 20, 2022 · Completed: Sep 30, 2027
1 condition
2 sponsors
4 locations
NCT05282108
Efficacy and Safety of Generic Imatinib (Carcemia®) Compared to Glivec® in Real-Life Management of Chronic Phase of Chronic Myeloid Leukemia
N/A
Recruiting
240 participants
Started: Jul 20, 2022 · Completed: Nov 30, 2026
1 condition
1 sponsor
4 locations
NCT05451953
Providing Oxygen During Intubation in the NICU Trial
NA
Recruiting
110 participants
Started: Jul 20, 2022 · Completed: Feb 28, 2027
2 conditions
3 sponsors
1 location
NCT05482763
Mycosis Culture Collection From Dermatological Isolated
N/A
Active, not recruiting
200 participants
Started: Jul 20, 2022 · Completed: Dec 25, 2025
3 conditions
1 sponsor
1 location
NCT05051397
CO2 Modulation in Endovascular Thrombectomy for Acute Ischemic Stroke
PHASE2
Recruiting
50 participants
Started: Jul 20, 2022 · Completed: Oct 19, 2026
5 conditions
1 sponsor
1 location
NCT05785143
Timing of Damage Control Orthopedic Surgery
N/A
Active, not recruiting
100 participants
Started: Jul 20, 2022 · Completed: Dec 31, 2032
1 condition
1 sponsor
1 location
NCT05260047
Culturally Responsive Community Driven Substance Use Recovery for Black and Latinx Population
NA
Recruiting
525 participants
Started: Jul 20, 2022 · Completed: Oct 1, 2026
4 conditions
2 sponsors
8 locations
NCT05388773
Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
PHASE2
Recruiting
150 participants
Started: Jul 20, 2022 · Completed: Dec 31, 2030
1 condition
1 sponsor
1 location
NCT04473794
Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
N/A
Recruiting
5,000 participants
Started: Jul 20, 2022 · Completed: Aug 1, 2036
2 conditions
2 sponsors
1 location
NCT05135975
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
PHASE2
Recruiting
86 participants
Started: Jul 20, 2022 · Completed: Dec 31, 2029
2 conditions
2 sponsors
6 locations
NCT06386705
TSN084 Treating Patients With Advanced Malignant Tumors
PHASE1
Recruiting
114 participants
Started: Jul 20, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
2 locations
NCT04845542
Promoting Resilience in Stroke Survivor-carepartner Dyads (ReStoreD)
NA
Recruiting
400 participants
Started: Jul 20, 2022 · Completed: Aug 31, 2027
4 conditions
1 sponsor
1 location
NCT06594315
Assessing Brain Metabolism Using MRS With Deuterated Glucose
N/A
Active, not recruiting
80 participants
Started: Jul 20, 2022 · Completed: Jul 31, 2027
1 condition
1 sponsor
1 location
NCT05150210
SP Thoracic IDE Study
NA
Active, not recruiting
32 participants
Started: Jul 20, 2022 · Completed: Jul 31, 2028
4 conditions
1 sponsor
6 locations
NCT06029517
A Sugar-Sweetened Beverage Reduction Intervention for Native American Men
NA
Active, not recruiting
48 participants
Started: Jul 20, 2022 · Completed: Sep 15, 2026
4 conditions
2 sponsors
1 location
NCT05408377
Effectiveness of Acupuncture for Cyclical Mastalgia (CM)
NA
Recruiting
108 participants
Started: Jul 20, 2022 · Completed: Dec 31, 2024
1 condition
3 sponsors
1 location
NCT05416411
Preoperative RESpiratory Training and MOBilization to Prevent Postoperative Pulmonary Complications in Patients Undergoing Thoracic Surgery
NA
Recruiting
436 participants
Started: Jul 20, 2022 · Completed: Jul 10, 2024
2 conditions
1 sponsor
3 locations
NCT05148364
Pain Resilience and Spiritual Health in Low Back Pain
N/A
Recruiting
15 participants
Started: Jul 20, 2022 · Completed: May 31, 2024
1 condition
1 sponsor
1 location
NCT05485649
Clinical Outcomes of Pregnant Individuals With Epilepsy - Prospective Study
N/A
Recruiting
80 participants
Started: Jul 20, 2022 · Completed: Jan 1, 2026
1 condition
1 sponsor
1 location
NCT05382299
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
PHASE3
Active, not recruiting
623 participants
Started: Jul 20, 2022 · Completed: Jul 31, 2028
2 conditions
1 sponsor
363 locations
NCT07210879
Early Predictors for Neurological Outcome After Traumatic Spinal Cord Injury
N/A
Active, not recruiting
800 participants
Started: Jul 20, 2022 · Completed: Aug 30, 2026
1 condition
3 sponsors
1 location
NCT05265273
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
PHASE2/PHASE3
Recruiting
12 participants
Started: Jul 20, 2022 · Completed: Jun 26, 2026
1 condition
1 sponsor
19 locations
NCT05450978
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
N/A
Recruiting
60 participants
Started: Jul 20, 2022 · Completed: Apr 1, 2028
2 conditions
2 sponsors
1 location
NCT05196087
Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)
N/A
Recruiting
500 participants
Started: Jul 20, 2022 · Completed: Jun 30, 2027
3 conditions
2 sponsors
1 location
NCT05626829
Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma
PHASE2
Recruiting
18 participants
Started: Jul 20, 2022 · Completed: Nov 30, 2024
2 conditions
1 sponsor
1 location
NCT06197880
Airway Morphology After En-masse Retraction in Bimaxillary Protrusion Patients
NA
Active, not recruiting
20 participants
Started: Jul 20, 2022 · Completed: Feb 1, 2024
1 condition
1 sponsor
1 location
NCT05334329
Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors
PHASE1
Active, not recruiting
6 participants
Started: Jul 20, 2022 · Completed: Jun 14, 2026
11 conditions
2 sponsors
1 location
NCT05197322
NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer
PHASE2
Recruiting
78 participants
Started: Jul 20, 2022 · Completed: Dec 31, 2028
1 condition
7 sponsors
5 locations
NCT05413850
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
PHASE1/PHASE2
Recruiting
82 participants
Started: Jul 20, 2022 · Completed: Mar 31, 2028
6 conditions
2 sponsors
5 locations
NCT05474079
Exercise Training & Statins for Cardiovascular Health
NA
Recruiting
80 participants
Started: Jul 20, 2022 · Completed: Jan 1, 2026
2 conditions
2 sponsors
1 location
Previous
1
More pages
1703
1704
1705
1706
1707
1708
1709
More pages
2369
Next